The Global Electrochemical Biosensors Market is expected to register a CAGR of 10.5% and is anticipated to reach USD 30,907.3 Million by 2025. Electrochemical biosensors are analytical devices used to provide analytical information by biological samples, such as tissues, enzymes, and whole cell, to an electrical signal. It is cost-effective, user-friendly, simple, disposable, and convenient
Market Overview
The growth of the market is likely to driven by increasing diabetic population, rising prevalence of chronic and lifestyle induced disease, increasing demand for POCT, increasing application of biosensors in various industries. However, factors such as strict regulatory requirements, reimbursement policies issues in healthcare systems is further hampering the market.
Applications of biosensors are increasing in various industries such as food, medical, environment, drug discovery, and security. Biosensors are used for detection and identification of diseases in crops and for measuring the level of pesticides, herbicides, and heavy metals in soil and ground water. Similarly, increasing presence of toxins, chemicals, and pathogens in food is a major concern. Biosensors are used to ensure quality and safety of products and detection of microbial pathogens and toxins in food and are cost-efficient.
Avail Free Sample Here: https://www.marketresearchfuture.com/sample_request/2792
In the recent years, there have been several initiatives and legislative actions for environmental pollution control. In addition, increasing social and scientific concerns about water quality control is increasing the demand for biosensors. Increasing number of harmful pollutants in the environment has also created a need for analytical and monitoring devices.
Major Key Players Competitive Analysis
Some of the Major players of this market are those that holds the largest market share of Electrochemical biosensors market: Hoffmann-La Roche AG; Medtronics; Bayer AG; Abbott Laboratories; I-SENS, Inc; Siemens Healthcare GmbH and others.
Market Segmentation
On the basis of applications the market is segmented into diagnosis, monitoring and others. Diagnosis segment has the largest market share in global electrochemical biosensors by application for the forecasted period from 2016 lasting till 2022.
Furthermore, on the basis of end users the market is segmented into point of care testing, diagnostics center, research laboratories and others.
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing Diabetic Population
4.2.2 Rising Prevalence Of Chronic And Lifestyle Induced Disease
4.2.3 Increasing Demand For POCT
4.2.4 Increasing Application Of Biosensors In Various Industries
4.3 Restraints
4.3.1 Strict Regulatory Requirements
4.3.2 Reimbursement Policies Issues In Healthcare Systems
4.4 Opportunities
4.4.1 Opportunity From Increasing Demand Of Personalized Medicine
Browse the data and market information presented in more than 54 market data tables and 29 figures spread over 73 pages of the project report. Go through the in-depth table of content (TOC) & market synopsis on “The Global Electrochemical biosensors Market Research Report -Forecast till 2022”: https://www.marketresearchfuture.com/reports/digital-therapeutics-market-6492
Regional analysis
As per Market Research Future analysis, the global electrochemical biosensors market has grown tremendously in Asia-Pacific. Geographically, North America holds the largest share of more than 43.0% of electrochemical biosensors market and is expected to be the leading market during 2016-2022. Usage of biosensor technology in North America is high as compared to other regions of the world due to technological advancements and broader application areas in different industries. Since, the healthcare expenditure is high in North America, biosensor devices are used extensively for accurate, reliable and quick results for early detection and prevention of diseases.
Similarly, according to European Federation of Pharmaceutical Industries and Associations, in 2012, the North American pharmaceutical market accounted for about 41% share of the total pharmaceutical market. This large market invests immensely in R&D of new drugs and thereby drives the demand for various biosensor devices for toxicity testing in the drug development process. Since, these biosensor devices are used in drug development and diagnosis, they are required to abide by certain regulations for efficacy and safety.
After North America region, Europe market is the second largest market in the global electrochemical biosensors market. Whereas Asia Pacific region is expected to be the fastest growing market due to increasing R&D funding by the developing countries like China and India for the development of biosensor products.
Ask for an Amazing Discount at: https://www.marketresearchfuture.com/check-discount/2792
Intended Audience
- Medical device manufacturers and distributors
- Government research organizations
- Hospitals and clinics
- Regulatory agencies
- Medical device companies
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312